BIBLIOGRAPHY
This new section of the site is dedicated to articles related to daclizumab, and provides detailed and analytical information for professional use.
These scientific documents focus primarily on its use, and cover specific areas such as medical studies, the latest clinical research and new advances taking place within the pharmaceutical industry.
If you cannot find a specific article in the chronological archives below, you can use the SEARCH box situated on the left hand column.
Daclizumab and Alemtuzumab as induction agents in adult intestinal and multivisceral transplantation: A comparison of two different regimens on 29 recipients during the early post-operative period.
Dig Liver Dis 2007 Mar;39(3):253-6
Induction therapy in lung transplantation: initial single-center experience comparing daclizumab and antithymocyte globulin.
Transplant Proc 2007 Jan-Feb;39(1):205-12
Anti-Tac (daclizumab, Zenapax) in the Treatment of Leukemia, Autoimmune Diseases, and in the Prevention of Allograft Rejection: A 25-Year Personal Odyssey.
J Clin Immunol 2007 Jan;27(1):1-18
[Half-dose Zenapax for acute rejection prevention after renal transplantation]
Nan Fang Yi Ke Da Xue Xue Bao 2006 Dec;26(12):1818-20